Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications

C Asakiya, L Zhu, J Yuhan, L Zhu… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction miRNA-derivative clinical nucleotide drugs (mdCNDs) effectively treat several
diseases, with numerous undergoing clinical trials. In early-stage trials in disease …
被引用次数：10 相关文章

Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications.

C Asakiya, L Zhu, J Yuhan, K Huang… - Expert Opinion on Drug …, 2022 - europepmc.org
miRNA-derivative clinical nucleotide drugs (mdCNDs) effectively treat several diseases, with
numerous undergoing clinical trials. In early-stage trials in disease therapeutics, such as …

Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications

C Asakiya, L Zhu, J Yuhan, L Zhu… - Expert opinion on …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction miRNA-derivative clinical nucleotide drugs (mdCNDs) effectively treat several
diseases, with numerous undergoing clinical trials. In early-stage trials in disease …